Concepedia

Dave Nellesen

DN

4

Publications

200

Citations

4

H-Index

2015

Active since

Affiliations

Analysis Group (United States)(Current)

Menlo School

Dave Nellesen is an author at Analysis Group (United States) specializing in medicine, breast cancer, and cancer therapeutics.

Top concepts

Publications per year

2015–2024

4

Publications

4

The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy Makers

David Proudman, Dave Nellesen · PharmacoEconomics · 2021 · 160 citations · Full text

Tazemetostat in relapsed/refractory follicular lymphoma: a propensity score-matched analysis of E7438-G000-101 trial outcomes

David Proudman, Deepshekhar Gupta, Dave Nellesen et al. · Oncotarget · 2022 · 16 citations · Full text

Short-term risk of recurrence in patients (pts) with HR+/HER2− early breast cancer (EBC) treated with endocrine therapy (ET) in randomized clinical trials (RCTs): A meta-analysis.

Giuseppe Curigliano, Eva Ciruelos, Kevin Kalinsky et al. · Journal of Clinical Oncology · 2024 · 14 citations

, , +20

Budget impact of pasireotide LAR for the treatment of acromegaly, a rare endocrine disorder

Jessica Zhang, Dave Nellesen, W.H. Ludlam et al. · Journal of Medical Economics · 2015 · 10 citations

Rows per page

1–4 of 4